FierceBiotech ١٨ ديسمبر ٢٠٢٥ Karuna head, Teva alums meet minds to launch schizophrenia-focused biotech Syremis with $165M series A
FierceBiotech ١٨ ديسمبر ٢٠٢٥ Verge Genomics drops sole clinical candidate in return to AI drug discovery roots
FierceBiotech ١٨ ديسمبر ٢٠٢٥ Takeda looks to 2026 FDA filing for its Sotyktu rival zasocitinib after phase 3 success
FierceBiotech ١٨ ديسمبر ٢٠٢٥ After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3
FierceBiotech ١٨ ديسمبر ٢٠٢٥ Lindus Health and Quotient team up to create one-stop shop for early to mid-stage trials
FierceBiotech ١٨ ديسمبر ٢٠٢٥ Voyager jettisons 30 employees, Novartis hands back rights to 2 programs
FierceBiotech ١٧ ديسمبر ٢٠٢٥ Oncology biotech Mythic and former fundraising heavyweight Areteia reach end of road
FierceBiotech ١٧ ديسمبر ٢٠٢٥ Norgine gets in on Vir's hepatitis D program with €550 European licensing pact
FierceBiotech ١٧ ديسمبر ٢٠٢٥ Fired NIH institute director sues Trump health officials, seeks reinstatement and backpay
FierceBiotech ١٧ ديسمبر ٢٠٢٥ Vistagen phase 3 study sees placebo surprise, putting future of social anxiety asset into question: analyst
FierceBiotech ١٧ ديسمبر ٢٠٢٥ Addition Tx does the math and emerges from stealth with $100M, biotech vets on exec team
FierceBiotech ١٧ ديسمبر ٢٠٢٥ Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B